Sophiris Bio, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013
For nine months, the company reported revenue of $5,000,000. Net loss before income tax expense was $5,211,000 compared to $15,863,000 a year ago. Net loss was $5,711,000 or $1.08 per basic and diluted share compared to $15,863,000 or $5.25 per basic and diluted share a year ago. Net cash flows used in operating activities was of $8,822,000 compared to $15,017,000 a year ago. Purchase of property and equipment was of $3,000 compared to $26,000 a year ago.